Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stage of non-Hodgkin's lymphomas

Christiansen, Ilse (author): Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,KITM

Sundström, Christer (author): Uppsala universitet,Institutionen för genetik och patologi

Kälkner, K. M. (author): Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Onkol

Bring, J. (author)

Tötterman, Thomas (author): Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,KITM

(creator_code:org_t)

1998
1998
English.
In: European Journal of Haematology. - 0902-4441 .- 1600-0609. ; 61:5, s. 311-318

Abstract Subject headings

The serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) were measured in 116 patients with non-Hodgkin's lymphomas (NHL) tested previously for soluble intercellular adhesion molecule-1 (sICAM-1). In contrast to Hodgkin's disease and chronic lymphocytic leukaemia, the sVCAM-1 levels in NHL patients were not significantly different from the levels of healthy controls (n=31). However, sVCAM-1 was elevated in advanced stage disease, i.e. stages III+IV. Elevated serum levels of sVCAM-1 were associated with significantly poorer disease-free (p = 0.024) and overall (p = 0.02) survival. sVCAM-1 correlated poorly with other known prognostic variables (LDH, sTK and beta2m) and with sICAM-1. None of the tested markers added prognostic information for disease-free survival independently of Ann Arbor stage and B-symptoms. The expression of VCAM-1 and ICAM-1 in tumour biopsies from 15 patients representing 7 different histologies were examined and compared with the serum levels of the soluble adhesion molecules. No correlation was found between the adhesion molecule expression by vascular endothelium and the corresponding serum levels.

By the author/editor: Christiansen, Il ...; Sundström, Chris ...; Kälkner, K. M.; Bring, J.; Tötterman, Thoma ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.